Active ingredients: Desloratadine
Neoclarityn 5 mg film-coated tablets.
Each tablet contains 5 mg desloratadine.
For a full list of excipients, see section 6.1.
Desloratadine is a non-sedating, long-acting histamine antagonist with selective peripheral H1-receptor antagonist activity. After oral administration, desloratadine selectively blocks peripheral histamine H1-receptors because the substance is excluded from entry to the central nervous system.
Calcium hydrogen phosphate dihydrate
Film coat (containing lactose monohydrate, hypromellose, titanium dioxide, macrogol 400, indigotin (E132))
Clear coat (containing hypromellose, macrogol 400)
Neoclarityn is supplied in unit dose blisters comprised of laminant blister film with foil lidding.
The materials of the blister consist of a polychlorotrifluoroethylene (PCTFE)/Polyvinyl Chloride (PVC) film (product contact surface) with an aluminium foil lidding coated with a vinyl heat seal coat (product contact surface) which is heat sealed.
Packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 100 tablets.
Not all pack sizes may be marketed.
Merck Sharp & Dohme Ltd
Date of first authorisation: 15 January 2001
Date of last renewal: 15 January 2006